Citius Pharmaceuticals, Inc.

US$0.55As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CTXRHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (44.90%)
Div yield —
ROE (81.09%)
Biotechnology
Beta (5Y) 1.04
PE TTM —
TSR TTM (65.50%)
Mkt cap US$14.96M
ROIC (47.02%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.661
21.21%
(28.07%)
Hold 4|8|12|12|1
1Q26
2Q26
3Q26
4Q26
Earnings per share$
0.01
0.01
0.01
0.01
22.13%
19.86%
21.30%
25.96%
Revenue$M
1.605
1.578
1.574
1.589
0.28%
0.81%
2.41%
3.98%
Peers (US$14.96M)
Cap (US$)
PE
15.10M
0.082x
Capital
TTM
5Y
10Y
Leveragex
1.712
0.917
0.789
EBIT/Intx
1.907
0.196
0.189
Own earn%
(89.66)
216.93
209.49
Sh yield%
22.48
10.36
8.91
Owners
Insiders/Inst%
2.77
36.93
Short interest%
3.47
SBC / revenue%
1.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
6–14
$1 testx
−0.5
Incr. ROIC%
3